Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$AAPL, $BIIB, $KR, $HUM
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Street’s Top analysts outlook for Key issues for Monday, as follows:
Apple Inc. (NASDAQ:AAPL) saw its price target at Loop Capital raised to 210 from 195. That compares with the Wall Street consensus price target of 200.06.
Biogen Inc. (NASDAQ:BIIB) was raised to Buy from Neutral at Citigroup. The 52-wk trading range for the biotechnology giant is 249.17 – 370.57. The consensus price target is 349.87. Last Thurday, the company said the new Alzheimer drug it is working on shows the potential to slow the disease.
Kroger Co. (NYSE:KR) was started with a Buy rating at Citigroup. The 52-wk trading range for the grocery giant is 19.69 – 31.35. The consensus price target is set at 30.18
Humana Inc. (NYSE:HUM) saw its price target raised at Piper Jaffray to 350 from 326. That compares with a consensus price target of 319.63. The stock closed Friday at 309.02.
Have a terrific week
The following two tabs change content below.
Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.